Supplementary Material for: Clinical Feasibility of Platinum-Based Chemotherapy Followed b

A clinical case series document describing three patients with metastatic urothelial carcinoma. The material details their treatment sequence with enfortumab vedotin plus pembrolizumab, followed by platinum-based chemotherapy and avelumab maintenance therapy. The document was authored by figshare admin karger and last updated on May 19, 2026.

Use Cases

• Analyze clinical feasibility of sequential therapies based on the described treatment regimen.
• Study patient outcomes after EVP therapy based on the case presentations.
• Evaluate the role of avelumab maintenance therapy based on the reported tumor regression.
• Investigate treatment strategies for patients with FGFR gene alterations based on the conclusion.

Strengths

• The document provides detailed clinical narratives for three specific patient cases.
• It is licensed under CC-BY-4.0, allowing for open sharing and reuse.
• The description explicitly discusses disease control, progression, and treatment discontinuation outcomes.

Limitations

• The dataset is a single 104.9 KB DOCX file, indicating a very limited scope.
• Row count and column-level documentation are absent; data structure must be inferred after download.
• The data may reflect bias inherent to a small case series from a single source.

Provenance

Source

figshare

Collection Method

Case series report authored by figshare admin karger.

Freshness

Last updated 2026-05-19 07:55:30; freshness should be verified.